Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • ABOUT THE IPILOGUE
    • BLOG
      • Announcements
      • Artificial Intelligence
      • Copyright
      • Innovation
      • IP Innovation Clinic
      • IP Intensive
      • Patents
      • Privacy
      • Technology
      • Trademarks
    • IPILOGUE TEAM
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
    • WRITE FOR US
  • IP INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • THE IP LUNCH CLUB
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • CONTESTS & COMPETITIONS
    • 2021 Oxford International Intellectual Property Law Moot
    • WIPO Short Story Competition: Indigenous Ingenuity and Creativity
    • IP WRITING CHALLENGE
    Home
    >
    IP
    >
    Patents
    >
    Pharmaceutical Drugs

    Category: Pharmaceutical Drugs

    October 28, 2022in Blogs, Pharmaceutical Drugs, Technology0by Editor
    595

    Pharmaceutical Giant Moderna sues Pfizer and BioNTech in the Aftermath of the COVID-19 Pandemic

    Nancy Chen is an IPilogue Writer and a second-year JD/MBA Candidate at the University of Toronto. In 2020, COVID-19’s emergence prompted scientists across the world to race against time to…

    Read more
    October 6, 2022in Blogs, IP, Patents, Pharmaceutical Drugs0by Editor
    674

    Another Win for BMS and Pfizer’s APIXABAN Patents

    Pankhuri Malik is an IPilogue Writer, IP Innovation Clinic Fellow, and an LLM Candidate at Osgoode Hall Law School. On August 04, 2022, the Federal Court of Appeal (“FCA”) reaffirmed…

    Read more
    April 22, 2022in Blogs, IP, Patents, Pharmaceutical Drugs0by Editor
    929

    Gilead and ViiV Healthcare Settle Global Patent Dispute for Over $1B USD

    Brandon Pierre is an IPilogue Writer and a 1L JD Candidate at Osgoode Hall Law School.   In a dizzying exception to an exception of a rule, the case of…

    Read more
    April 18, 2022in Blogs, IP, Patents, Pharmaceutical Drugs0by Editor
    805

    Ceasing Patent Enforcement from Alternative Perspectives: Russia and Moderna

    Andrew Masson is an IPilogue Writer and 1L at Osgoode Hall Law School.   Two major pieces of patent protection news with global long-lasting significance dropped in early March for…

    Read more
    February 1, 2022in Blogs, IP, Pharmaceutical Drugs0by Editor
    803

    The Competition Bureau And Health Canada Issue Joint Notice On Continued Collaboration In Pharmaceutical Sector

    M. Imtiaz Karamat is an IP Osgoode Alumnus and Associate Lawyer at Deeth Williams Wall LLP. This article was originally posted on E-TIPS™ For Deeth Williams Wall LLP on January 26,…

    Read more
    January 24, 2022in Blogs, IP, IP Intensive, Patent Practice, Patents, Pharmaceutical Drugs0by Editor
    1133

    It’s a Small World in Big Pharma - My Internship at TEVA Canada Ltd.

    Vivian Sim is an IP Intensive student and a 3L JD candidate at Osgoode Hall Law School. As part of the course requirements, students were asked to write a reflective…

    Read more

    Posts navigation

    1 2 … 19
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736